Home Cellular Gene editing

Gene editing

Ervaxx exits stealth mode with $17.5 million

UK start-up Ervaxx targets 'dark matter' genes to develop cell therapies. After two years in stealth mode, the new UK-based start-up Ervaxx has stepped out of...

Prime editing set to take slice from CRISPR

Better than CRISPR? A new prime-editing tool could  correct 89% of the known human genetic variants and be more accurate and versatile than CRISPR. Enter...

Hacking Longevity: Exclusive with Jamie Metzl

Jamie Metzl is a technology and healthcare futurist and geopolitical expert, novelist, entrepreneur, media commentator, and Senior Fellow of the Atlantic Council. In February 2019,...

Researchers pin Longevity hopes on new gene editor

$34M in new Trucode funding could challenge CRISPR domination of genetic engineering market. Have we reached the thin end of the CRISP? For scientists looking...

Genetic biomarkers for Longevity discovered

International research group finds 17 different genetic interventions that extend life. Researchers in Moscow and Harvard have been able to identify a group of genes...

Link found between telomeres and pluripotent stem cells

A simple cell 'twitch' can determine whether a cell retains its 'be anything' superpower or becomes allocated to one single role. The butterfly effect is...

Healthspan breakthrough as unique molecule discovered that reverses memory loss

Breakthrough by Stanford University researchers reverses brain decline by disabling a single molecule to improve cognitive healthspan. New research conducted by neurobiologist Tony Wyss-Coray’s team...

New CRISPR therapy suppresses accelerated aging in mice

Novel treatment for progeria sheds light on genetic component of aging. There is still much to disentangle when it comes to understanding the genetic basis...

Type I CRISPR-Cas tackles DNA editing on a much larger scale – could revolutionise Longevity

This new shredding technique will revolutionise Longevity medicine and tackle hypertension, heart disease, cancer, neurodegenerative diseases and diabetes. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)...

Longevity expansion as first pluripotent stem cell treatment ready for human trials

Successful treatment for macular degeneration in mice paves a new way for expanding the Longevity field. Stem cell treatment is feasible, and has been for...

ADVERT

ADVERT

Latest articles

UK doctors told to ignore consumer genetic tests

Royal College of General Practitioners guidance places significant doubt on consumer genetic testing. Consumer interest in genetic testing has grown in popularity in recent years,...

New study shows rapamycin slows Alzheimer’s

A new study from UT Health San Antonio suggests the drug rapamycin may be able to slow the rate of brain-related blood flow decreases. The...

Meet the Startup: Kintell’s take on Alexa Skills

New IoT device focuses on prolonging independence for the broader aging population. While there are many technologies out there designed to help older people who...

The Longevity Week: Addressing global Longevity

A packed week of multidisciplinary events with a global focus on the Longevity challenge. One year ago, the first Longevity Forum event was held in...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.